Hefei Xinzhu Biotechnology

Hefei Xinzhu Biotechnology is an innovative biopharmaceutical company based in Hefei, China, dedicated to the development of novel small molecule drugs through targeted protein degradation (TPD) technologies. The company specifically focuses on the discovery of molecular glue degraders, which enable the degradation of disease-causing proteins that are otherwise difficult to target with traditional inhibitors. Hefei Xinzhu's research and development efforts are primarily directed toward oncology and autoimmune diseases, with several programs in the discovery and preclinical stages. By utilizing its proprietary platform, the company aims to expand the druggable proteome and deliver transformative therapies to patients with high unmet medical needs. Based in the Hefei High-tech Zone, the company is supported by regional venture capital and a team of experienced drug discovery professionals.